EP 1086083 A1 20010328 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASEINHIBITOREN
Title (fr)
INHIBITEURS DE PROTEASES
Publication
Application
Priority
- US 9913334 W 19990611
- US 8905698 P 19980612
Abstract (en)
[origin: WO9964399A1] This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, which are inhibitors of cysteine proteases, particularly cathepsin K, and are useful in the treatment of diseases in which inhibition of bone loss is a factor.
IPC 1-7
IPC 8 full level
A61K 31/40 (2006.01); A61K 31/4709 (2006.01); A61P 1/02 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 43/00 (2006.01); C07D 207/12 (2006.01); C07D 207/24 (2006.01); C07D 401/12 (2006.01); C07D 413/14 (2006.01)
CPC (source: EP)
A61P 1/02 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 43/00 (2017.12); C07D 207/24 (2013.01); C07D 401/12 (2013.01); C07D 413/14 (2013.01)
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9964399 A1 19991216; AR 018652 A1 20011128; AU 4564499 A 19991230; CA 2334652 A1 19991216; CO 5040090 A1 20010529; DZ 2815 A1 20031201; EP 1086083 A1 20010328; EP 1086083 A4 20010926; JP 2002517485 A 20020618; MA 24877 A1 19991231; PE 20000725 A1 20000928
DOCDB simple family (application)
US 9913334 W 19990611; AR P990102767 A 19990610; AU 4564499 A 19990611; CA 2334652 A 19990611; CO 99036559 A 19990610; DZ 990115 A 19990609; EP 99928614 A 19990611; JP 2000553408 A 19990611; MA 25619 A 19990610; PE 00051899 A 19990611